Fig. 4From: Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors A working hypothesis: Circulating β-aminoisobutyric acid (BAIBA) mediates SGLT2i-induced cardioprotection. This figure was created with BioRender.com. SGLT2i, sodium-glucose cotransporter inhibitor; BAIBA, β-aminoisobutyric acid; FFA, free fatty acid; FA, fatty acidBack to article page